The RPL3L gene helps heart and skeletal muscle cells make the proteins they need to work well. This gene plays an important role in keeping muscle cells working smoothly, especially in the heart. If it does not work properly, some people may develop an uneven heart rhythm called atrial fibrillation or a weakened, enlarged heart muscle. Different variants can have different effects, and some may have little impact on health.
What is a gene?
Genes are stretches of DNA that provide cells with instructions to make molecules or manage processes in the body. Some genes hold the code for proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they take place, and how strongly they are carried out. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a more in depth look at this topic, you can learn more in the LearnHub.
Overview
RPL3LGene function
What if the gene works
The RPL3L gene helps muscle cells, especially in the heart, make part of the cell's protein-making machinery. This supports normal protein production, which helps muscles grow, repair, and work properly.
Risk
What if the gene does not work
Variants in the RPL3L gene can affect heart muscle function. Milder variants may raise the chance of atrial fibrillation, while more severe variants can cause early dilated cardiomyopathy, often with symptoms ranging from mild rhythm problems to severe heart failure.
Treatment
What does that mean for your treatment
No treatment or management approach is currently established specifically for pathogenic variants in the RPL3L gene. Care is usually guided by a person’s heart findings, such as rhythm changes or cardiomyopathy, and the RPL3L gene is mainly being studied as a marker of cardiac risk rather than a current drug target.
Conditions associated with RPL3L
Gene function
What if the gene works
The RPL3L gene is most active in heart and skeletal muscle. It helps these cells make part of the ribosome, the protein-making machinery inside cells. In everyday terms, RPL3L gene function in heart and skeletal muscle supports the steady protein production needed for normal muscle work.
The RPL3L gene provides instructions for a protein that becomes part of the ribosome, your cells’ protein-making machinery. In working muscle cells, that protein joins the large ribosome half used to build new proteins.
This gene supports the step where cells read RNA messages and assemble proteins. In heart and skeletal muscle, steady protein production helps cells maintain their normal structure and daily workload.
RPL3L is used mainly in heart and skeletal muscle rather than across the whole body. This gives these muscle cells a ribosome component suited to their ongoing need for protein renewal.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not produce any noticeable effect and simply reflect natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RPL3L gene can change the shape of its protein or leave cells with too little of it, which may disrupt ribosome assembly and protein production in heart muscle cells. Milder variants may partly reduce this effect, while more severe loss of function variants can remove it almost completely. This helps explain how RPL3L gene variants affect the heart, and why more disruptive changes may be linked to earlier or more marked heart findings in some people.
How variants are linked to conditions
Variants in the RPL3L gene are most clearly linked to atrial fibrillation, a common irregular heart rhythm, in human genetic studies. Some RPL3L gene variants have also been reported in people with cardiomyopathy, especially dilated cardiomyopathy, though that link is less firmly established. For common risk variants, these associations can raise or lower the chance of disease, but they do not guarantee that a heart condition will develop.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen in the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a role. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the RPL3L gene. Some changes in RPL3L have been linked with heart rhythm problems or heart muscle disease, but personal risk can vary, so people with concerns should speak with a doctor or genetic counselor.
Inheritance of RPL3L variants
For families asking how RPL3L variants are inherited, the well-established pattern for RPL3L-related inherited heart disease is autosomal recessive. This means a person usually needs to inherit two changed copies of the RPL3L gene, one from each parent, to have the condition. Parents with one changed copy are typically carriers, and when both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child with two usual copies.
What does my RPL3L result mean for my family?
For families with an RPL3L-related heart condition, this is most often described in a recessive pattern, which means parents may be healthy carriers while brothers and sisters could also have the condition or be carriers. Close relatives may want to learn whether the same gene change is present, especially if there is a family history of serious heart problems in infancy or childhood.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the RPL3L gene usually uses a blood or saliva sample. A lab reads the DNA code to look for changes, and RPL3L genetic testing can show whether a variant linked to an inherited heart condition is present.
When should I consider getting a genetic test?
Genetic testing that includes the RPL3L gene may be considered if you or close relatives have early or unexplained heart rhythm problems, especially atrial fibrillation, or an inherited heart muscle condition. Testing is usually done as part of a broader heart gene panel, with results reviewed alongside personal and family history.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal depends on the condition and the specific type of variant involved. Over time, many factors shape how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else. Small differences in genes can change how the body absorbs, breaks down, or responds to a drug, and these differences are common. In practice, this can influence how strongly a medicine works or how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medication. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect how strongly a drug works or how the body processes it. This information can support more informed and more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the RPL3L gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices. Questions about medications, side effects, or heart-related symptoms are best discussed with your doctor.